• Tofranil, imipramine hydrochloride USP, the original tricyclic antidepressant, is a member of the dibenzazepine group of compounds. (nih.gov)
  • Imipramine is a tricyclic antidepressant that continues to be widely used in the therapy of depression. (nih.gov)
  • Imipramine (im ip' ra meen) is a dibenzazepine derived tricyclic antidepressant which acts by inhibition of serotonin and norepinephrine reuptake within synaptic clefts in the central nervous system, thus increasing brain levels of these neurotransmitters. (nih.gov)
  • Anyone considering the use of imipramine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. (nih.gov)
  • Imipramine hydrochloride USP is a white to off-white, odorless, or practically odorless crystalline powder. (nih.gov)
  • The possibility of cross-sensitivity to other dibenzazepine compounds should be kept in mind. (nih.gov)
  • The first TCA reported for the treatment of depression was imipramine, a dibenzazepine analogue of chlorpromazine code-named G22355. (wikipedia.org)
  • The mechanism of action of Tofranil is not definitely known. (nih.gov)
  • The mechanism by which imipramine causes serum aminotransferase elevation is not known. (nih.gov)
  • When it is desired to substitute Tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. (nih.gov)
  • Liver test abnormalities have been reported to occur in up to 20% of patients on long term therapy with imipramine, but elevations are uncommonly above 3 times the upper limit of normal. (nih.gov)